This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

IPC The Hospitalist Company Elects Robert Wachter, M.D. To Its Board Of Directors

NORTH HOLLYWOOD, Calif., Aug. 1, 2013 (GLOBE NEWSWIRE) -- IPC The Hospitalist Company, Inc. (Nasdaq:IPCM), a leading national hospitalist physician practice company, announced today that Robert Wachter, M.D. has been elected to the company's board of directors, effective immediately. In addition to serving as an independent director, Dr. Wachter will be chair of the board's quality committee.

Dr. Wachter is professor and associate chair of the Department of Medicine at the University of California, San Francisco, where he directs the 60-physician Division of Hospital Medicine. Author of 250 articles and six books, Dr. Wachter coined the term "hospitalist" in 1996 and is widely considered the "father" of the hospitalist field, one of the fastest growing specialties in the history of modern medicine. He is past president of the Society of Hospital Medicine, and the immediate past-chair of the American Board of Internal Medicine.

A noted expert in patient safety and quality of care, Dr. Wachter edits the U.S. government's two leading websites on safety and has written two bestselling books on the subject. In 2004, he received the John M. Eisenberg Award, the nation's top honor in patient safety. For the past six years, Modern Healthcare magazine has named him one of the 50 most influential physician-executives in the U.S., the only academic physician to earn that distinction. He has served on the healthcare advisory boards of several companies, including Google. His blog, , is one of the nation's most popular healthcare blogs. In 2011, he studied patient safety and hospital medicine at Imperial College London as a Fulbright Scholar.

Dr. Wachter noted, "My entire career has been focused on improving the quality, safety, and efficiency of the care we deliver to our patients. This mission has never been more important than it is today, and hospitalists must be at its cutting edge. For the past several years, my UCSF colleagues and I have collaborated with IPC to deliver a world-class training program to the Company's emerging leaders, and I have been impressed by the organization's steadfast commitment to improvement. IPC's 1,400 hospitalists now have more than 6 million patient encounters each year – about 16,000 each day – in hospitals and post-acute care facilities throughout the country. Joining IPC's board of directors provides me an unmatched opportunity to help shape the future of healthcare – to make things better for patients, for physicians, and for the healthcare system. I look forward to doing what I can to help the company reach its full potential."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.24 -0.41%
FB $117.81 -0.21%
GOOG $701.43 0.82%
TSLA $211.53 -4.96%
YHOO $36.94 2.61%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs